Promino Nutritional increases financing to $1.72M

Executive Summary

• Promino Nutritional Sciences Inc. upsized its previously announced private placement, increasing the maximum gross proceeds from $1.5 million to $1.725 million.
• The company will sell up to 57.5 million units at C$0.03 per unit; each unit includes one common share and one warrant exercisable at C$0.06 for 12 months.
• Net proceeds are earmarked to accelerate growth through inventory investments and general corporate purposes (excluding officer salaries and investor‑relations fees).

Key Details

• Upsized Offering Size: Maximum gross proceeds increased to C$1,725,000 (from C$1,500,000).
• Units Offered: Up to 57.5 million units at C$0.03 per unit.
• Unit Composition: Each unit = 1 common share + 1 common share purchase warrant.
• Warrant Terms: Warrants allow purchase of one additional share at C$0.06 per share; exercisable for 12 months from issuance date.
• Use of Proceeds:
• Accelerate growth via inventory investments.
• General corporate purposes (excluding accrued salaries to officers/directors and investor‑relations activities).
• Finder’s Fees: Company may pay finder’s fees in accordance with applicable securities laws and CSE rules.
• Other Terms: All other terms of the original private placement remain unchanged.

Notable Quotes

(No executive quotes provided in the release.)